Name: Dilip Nathwani, MB, ChB.  
Dilip Nathwani  

Post currently held: Consultant Physician and Honorary Reader in Medicine and Infectious Diseases

Degrees & Diplomas:
DTM&H
 
FRCP (Ed)
 
   

Main Research Interest:
Cost effectiveness strategies in rationalising antibiotic sepsis management; quality indicators in infectious diseases; impact of best practice guidelines and antibiotic policy on clinical and economic outcomes; quality assurance in outpatient & home parenteral antibiotic therapy

Main Clinical Interest:
Implementation and evaluation of guidelines for sepsis management; implementation and evaluation of an outpatient and home parenteral antibiotic therapy programme; travel medicine; continuing medical education in infection.
Other Activities/Editorships
  
Editor in Chief of CME bulletin in Infection and Tropical Medicine
Ex Assistant Editor of the Journal of Antimicrobial Chemotherapy
Secretary of Specialist Advisory Committee for Training in Infectious Disease and Tropical Medicine (JCHMT)
Chairman of the SIGN development group for "Surgical antibiotic prophylaxis"
Chairman of the Dundee Teaching Hospitals NHS Trust Quality and Clinical Effectiveness Group

 

Most Recent Publications
Barlow G, Sachdev N, Nathwani D. The Use of adult isolation facilities in a UK infectious diseases unit. J Hosp Infect 2002; 50: 127-132.
Nathwani D, Williams F, Winter J, Winter, J, Ogston S, Davey P. Use of indicators to evaluate the quality of community acquired pneumonia management. Clin Infect Dis 2002; 34: 318-329.
Nathwani D, Tice A. Ambulatory antimicrobial use: the value of an outcomes registry. Journal of Antimicrobial Chemotherapy 2002; 49: 149-154.
Barlow G, Mukherjee R, Jones M, Nathwani D. Unnecessary peripheral intravenous catheterisation on an acute medical admissions unit: a pilot study. European J Internal Medicine 2002; 13: 380-384.
Nathwani D, Barlow G, Adjukiewicz K, Gray K, Clift B, France A, Davey P. Cost minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory Teicoplanin, inpatient care or outpatient linezolid therapy. Journal of Antimicrobial Therapy 2003; 51: 391- 396.
Nathwani D, McIntyre PG, White K, Shearer AJ, Reynolds N, Walker D, Orange GV, Fooks AR. Fatal human rabies caused by European bat lyssavirus type 2a infection in Scotland. Clinical Infectious Diseases 203; 37: 598 - 601.
Nathwani D, Jim Z Li, Dan A Balan, Richard J Wilkie, Brian E Rittenhouse, Essy Mozaffari, Manouche Tavakoli, Tom Tang and the Linezolid Study Team. Economic evaluation of linezolid versus Teicoplanin for the treatment of gram-positive bacterial infections in hospitalised patients in Europe: results from a multinational trial. International Journal of Antimicrobial Agents, in press 2003.
Nathwani D, Tillotson GS. Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era? Commentary International Journal of Antimicrobial Agents 2003; 21: 521 - 524.
Nathwani D. (invited editorial). From Evidence Based Guideline Methodology to Quality of Care Standards. Journal of Antimicrobial Chemotherapy 2003; 51: 1103-1108.
Barlow G, Lamping D, Davey P, Nathwani D. Evaluating outcomes in community acquired pneumonia: A guide for patients, physicians and policy makers. Lancet Infectious Diseases 2003; 3: 476-88.

 

Address
  
   
Secretaries
    
   
Irene Stewart
 
Karen Kathro
 
 
 
 

 

A to Z Index | Search the University

Maintained by: a.z.hill@dundee.ac.uk.

Disclaimer | Privacy

Page last updated: Thursday 25 March 2010 02:29 PM